0001013594-20-000496.txt : 20200514
0001013594-20-000496.hdr.sgml : 20200514
20200514182555
ACCESSION NUMBER: 0001013594-20-000496
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200512
FILED AS OF DATE: 20200514
DATE AS OF CHANGE: 20200514
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Paulson John
CENTRAL INDEX KEY: 0001394923
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14956
FILM NUMBER: 20879721
MAIL ADDRESS:
STREET 1: 1133 AVENUE OF THE AMERICAS
STREET 2: 33RD FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10036
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Bausch Health Companies Inc.
CENTRAL INDEX KEY: 0000885590
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: NJ
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2150 ST. ELZEAR BLVD. WEST
STREET 2: LAVAL
CITY: QUEBEC
STATE: A8
ZIP: H7L 4A8
BUSINESS PHONE: 514-744-6792
MAIL ADDRESS:
STREET 1: 2150 ST. ELZEAR BLVD. WEST
STREET 2: LAVAL
CITY: QUEBEC
STATE: A8
ZIP: H7L 4A8
FORMER COMPANY:
FORMER CONFORMED NAME: Valeant Pharmaceuticals International, Inc.
DATE OF NAME CHANGE: 20100928
FORMER COMPANY:
FORMER CONFORMED NAME: BIOVAIL Corp
DATE OF NAME CHANGE: 20100416
FORMER COMPANY:
FORMER CONFORMED NAME: BIOVAIL CORP INTERNATIONAL
DATE OF NAME CHANGE: 19960522
4
1
form4.xml
X0306
4
2020-05-12
0000885590
Bausch Health Companies Inc.
BHC
0001394923
Paulson John
1133 AVENUE OF THE AMERICAS
33RD FLOOR
NEW YORK
NY
10036
true
Common Stock, no par value
2020-05-12
4
P
0
25000
17.3
A
20864035
I
By Managed Funds
Common Stock, no par value
2020-05-12
4
P
0
162900
17.5
A
21026935
I
By Managed Funds
Common Stock, no par value
2020-05-12
4
P
0
374836
17.33
A
21401771
I
By Managed Funds
Common Stock, no par value
2020-05-12
4
P
0
678400
17.47
A
22080171
I
By Managed Funds
Common Stock, no par value
2020-05-12
4
P
0
799900
17.24
A
22880071
I
By Managed Funds
Common Stock, no par value
2020-05-13
4
P
0
603900
16.32
A
23483971
I
By Managed Funds
Common Stock, no par value
2020-05-13
4
P
0
80300
16.58
A
23564271
I
By Managed Funds
Common Stock, no par value
2020-05-13
4
P
0
645844
16.7
A
24210115
I
By Managed Funds
Common Stock, no par value
2020-05-14
4
P
0
348920
15.85
A
24559035
I
By Managed Funds
Common Stock, no par value
2020-05-14
4
P
0
70000
15.65
A
24629035
I
By Managed Funds
Common Stock, no par value
2020-05-14
4
P
0
624900
15.87
A
25253935
I
By Managed Funds
Common Stock, no par value
2020-05-14
4
P
0
585100
15.92
A
25839035
I
By Managed Funds
John Paulson, the controlling person of Paulson & Co. Inc. ("Paulson"), serves on the board of directors of the Issuer. Paulson is an investment advisor registered under the Investment Advisors Act of 1940. Paulson is the investment manager of investment funds (the "Funds"). John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Act"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person.
/s/ John Paulson
2020-05-14